2680eP Metastatic fumarate hydratase-deficient renal cell carcinoma (FHRCC): outcome on first-line immune checkpoint inhibitor (ICI) combination: a multicenter retrospective study (FUMAHRE study).
Saved in:
| Title: | 2680eP Metastatic fumarate hydratase-deficient renal cell carcinoma (FHRCC): outcome on first-line immune checkpoint inhibitor (ICI) combination: a multicenter retrospective study (FUMAHRE study). |
|---|---|
| Authors: | Guida, A.1 (AUTHOR), Bimbatti, D.2 (AUTHOR), Di Marco, A.2 (AUTHOR), Calabrese, M.3 (AUTHOR), Beuselinck, B.4 (AUTHOR), Ciccarese, C.5 (AUTHOR), Quattrocchi, A.M.O.6 (AUTHOR), Messina, C.7 (AUTHOR), Conteduca, V.8 (AUTHOR), Stellato, M.9 (AUTHOR), Maiorano, B.A.10 (AUTHOR), Mammone, G.1 (AUTHOR), Imperi, M.11 (AUTHOR), Francesconi, S.12 (AUTHOR), Gili, A.13 (AUTHOR), Albiges, L.14 (AUTHOR), Bracarda, S.15 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1430-S1430. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189421054 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 2680eP Metastatic fumarate hydratase-deficient renal cell carcinoma (FHRCC): outcome on first-line immune checkpoint inhibitor (ICI) combination: a multicenter retrospective study (FUMAHRE study). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Guida%2C+A%2E%22">Guida, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bimbatti%2C+D%2E%22">Bimbatti, D.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Di+Marco%2C+A%2E%22">Di Marco, A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Calabrese%2C+M%2E%22">Calabrese, M.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Beuselinck%2C+B%2E%22">Beuselinck, B.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ciccarese%2C+C%2E%22">Ciccarese, C.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Quattrocchi%2C+A%2EM%2EO%2E%22">Quattrocchi, A.M.O.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Messina%2C+C%2E%22">Messina, C.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Conteduca%2C+V%2E%22">Conteduca, V.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stellato%2C+M%2E%22">Stellato, M.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maiorano%2C+B%2EA%2E%22">Maiorano, B.A.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mammone%2C+G%2E%22">Mammone, G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Imperi%2C+M%2E%22">Imperi, M.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Francesconi%2C+S%2E%22">Francesconi, S.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gili%2C+A%2E%22">Gili, A.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Albiges%2C+L%2E%22">Albiges, L.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bracarda%2C+S%2E%22">Bracarda, S.</searchLink><relatesTo>15</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS1430-S1430. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189421054 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.3291 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S1430 Titles: – TitleFull: 2680eP Metastatic fumarate hydratase-deficient renal cell carcinoma (FHRCC): outcome on first-line immune checkpoint inhibitor (ICI) combination: a multicenter retrospective study (FUMAHRE study). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Guida, A. – PersonEntity: Name: NameFull: Bimbatti, D. – PersonEntity: Name: NameFull: Di Marco, A. – PersonEntity: Name: NameFull: Calabrese, M. – PersonEntity: Name: NameFull: Beuselinck, B. – PersonEntity: Name: NameFull: Ciccarese, C. – PersonEntity: Name: NameFull: Quattrocchi, A.M.O. – PersonEntity: Name: NameFull: Messina, C. – PersonEntity: Name: NameFull: Conteduca, V. – PersonEntity: Name: NameFull: Stellato, M. – PersonEntity: Name: NameFull: Maiorano, B.A. – PersonEntity: Name: NameFull: Mammone, G. – PersonEntity: Name: NameFull: Imperi, M. – PersonEntity: Name: NameFull: Francesconi, S. – PersonEntity: Name: NameFull: Gili, A. – PersonEntity: Name: NameFull: Albiges, L. – PersonEntity: Name: NameFull: Bracarda, S. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |